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Challenges of using protein antibiotics for
pathogen control
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Abstract
Bacterial phytopathogens represent a significant threat tomany economically important crops. Current control measures often
inflict harm on the environment and may ultimately impact on human health through the spread of antibiotic resistance. Anti-
microbial proteins such as bacteriocins have been suggested as the next generation of disease control agents since they are
able to specifically target the pathogen of interest with minimal impact on the wider microbial community and environment.
However, substantial gaps in knowledge with regards to the efficacy and application of bacteriocins to combat phytopatho-
genic bacteria remain. Here we highlight the immediate challenges the community must address to ensure maximum exploita-
tion of antimicrobial proteins in the field.
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1 INTRODUCTION
The global population is predicted to exceed 9 billion by 2050 and
this will require a substantial increase in food availability. In 2020,
it is estimated that 690 million people (8.9% of the world popula-
tion) are hungry.1 This is expected to worsen due to the impacts of
the COVID-19 pandemic, which is predicted to add a further
83 million to 132 million people that are undernourished.1 Fur-
thermore, global warming and deteriorating economic growth
in many countries has exacerbated food security issues. One of
the ways in which food security can be improved is by preventing
crops losses caused by pests such as bacterial phytopathogens. It
is estimated that even with current biocontrol methods the losses
caused to the fivemajor crops by phytopathogens, i.e. wheat, rice,
maize, potatoes and soybeans, are still as high as 10.2%, 10.8%,
8.5%, 14.5% and 8.9%, respectively.2 Moreover, measures to con-
trol bacterial plant diseases often have undesirable environmen-
tal side effects. For instance, some chemical sprays and seed
treatments contain amounts of copper that are harmful to the
environment and with copper resistance developing in target
bacteria are becoming less effective.3 More disturbingly, control
methods for some bacterial phytophathogens include using anti-
biotics, in particular streptomycin and oxytetracycline, that are
also used as therapeutics in human medicine, potentially driving
the spread of resistance in the wider microbial community and
in human pathogens.
Bacteriocins are antimicrobial proteins produced by many bac-
teria that have evolved to kill closely related competitors. As a
result, bacteriocins tend to have a highly specific killing range
allowing the normal microflora to remain undisturbed. They rep-
resent a currently unexploited novel source of antimicrobials for
use against bacterial phytopathogens. Economically important
phytopathogenic bacteria (typically, gram-negative) are
responsible for some of the most damaging diseases, including
black leg and soft rot in potatoes caused by Pectobacterium and
Dickeya species and more promiscuous bacteria such as Pseudo-
monas syringae and Xanthomonas spp. that infect many different
types of plants.4 Several bacteriocins that have already been iden-
tified and characterized show killing activity against these bacte-
rial genera, representing promising potential control agents.
This review explores how bacteriocins can be exploited as biocon-
trol agents to treat bacterial infections of crops and the challenges
that need to be overcome for this to happen.
2 IDENTIFICATION OF NOVEL
BACTERIOCINS
Compared to conventional antibiotics, bacteriocins show much
greater target specificity. Therefore, for bacteriocins to be practi-
cal antimicrobials, access to a very extensive armory of different
bacteriocins will be essential. Fortunately, because bacteriocin
production is almost ubiquitous amongst gram-negative bacteria,
the potential for bacteriocin discovery is very great – what is
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required are efficient strategies for identifying and characterizing
novel bacteriocins.
Historically, bacteriocins were identified by testing filtrates/
extracts of suspected bacteriocin producers for inhibitory activity
against potentially sensitive target strains. For example, three bac-
teriocins from Xanthomonas were identified following the obser-
vation that in many Florida tomato fields infections by
X. euvesicatoria were quickly outcompeted by X. perforans.5 This
was subsequently attributed to the production of bacteriocins
by X. perforans.6 Until recently, direct testing for activity was the
only practical strategy for identifying bacteriocins from phyto-
pathogens and several Xanthomonas bacteriocins,7,8 ulceracin
378 from Corynebacterium ulcerans,9 two bacteriocins from Erwi-
nia carotovora CGE234-M40310 and several bacteriocins from
pseudomonads11 were identified in this way. However, this
approach is time-consuming and has a high rate of rediscovery
so despite the widespread production of bacteriocins (and its his-
torically important role in bacteriocin discovery) this approach
does not provide an efficient strategy for the high-throughput
programmes that will be required to identify bacteriocins in the
numbers that will be needed for widespread uptake of the
technology.
Amuchmore efficient strategy for identifying bacteriocins is the
identification of gene sequences encoding prospective bacterio-
cins by genome mining. The commercialization of next-
generation sequencing has led to a boom in publicly available
genome sequences, an immense resource from which bacterio-
cins can be identified using bioinformatic approaches. For exam-
ple, at the end of 2010 there were 13 published Xanthomonas
genomes in NCBI, currently (December 2020) there are 1610
genomes available. Bacteriocin searches range from straightfor-
ward BLAST searches (using complete or partial sequences from
different classes of known bacteriocins) to more complex algo-
rithms and the use of machine learning to identify more diverse
bacteriocins.12–14
BLAST searches have typically been performed by searching for
homology to well characterized bacteriocins, e.g. colicins from
E. coli and pyocins from P. aeruginosa. The colicin-like bacteriocins
are typically modular and are organized into different domains
based on their function (e.g. targeting specificity and catalytic/kill-
ing activity). The domains are interchangeable between different
bacterial strains so closely related bacterial strains may produce
bacteriocins that share one domain but differ in another. Often,
matches to a single domain allow for the identification of novel
bacteriocins, for example the Pectobacterium bacteriocins Pecto-
cin M1 and M2. These share a cytotoxic domain with colicin M,
but the N-terminal regions, comprising the translocation and
receptor domains, are completely different and on subsequent
investigation were shown to share a high level of similarity to
plant ferredoxins.15 Importantly, this led directly to the identifica-
tion of another putative pectobacterial bacteriocin, pectocin P,
which also has an N-terminal ferredoxin domain but harbors a
cytotoxic domain that shares structural homology with lysozyme.
These results show the value of iteratively using homology
searches to uncover novel bacteriocins from genome sequences.
Despite these promising results, relying on BLAST searches can
be limited by an over-reliance on the use of well characterized
classes of bacteriocins such as colicins and pyocins in searches.
Consequently, novel classes of bacteriocins may be overlooked.
For some genus of gram-negative phytopathogenic bacteria this
leads to a paucity of hits – bacteriocins produced by them are
either evolutionarily distant or have evolved completely
independently. To address this problem there have been several
attempts to develop new algorithms with less conserved and/or
novel search parameters as a route to discovering new bacterio-
cins.16 This approach has enjoyed some success in identifying
bacteriocins that may have been overlooked by the usual bioin-
formatics routes.
Whatever the strengths and weaknesses of the different
approaches, given that most bacteria produce bacteriocins,
with some producing several, the range and number of as-yet
unidentified bacteriocins is clearly very great and represent a
highly promising and currently underutilized source of
antimicrobials.
3 BACTERIOCIN RESISTANCE
The development of bacterial resistance to conventional antibi-
otics is a well-documented and ongoing problem and bacteria
similarly evolve resistance to bacteriocins. With conventional anti-
biotics, resistance typically involves the acquisition of genes, often
plasmid borne, encoding enzymes that either break down or
detoxify the antibiotic.17 Resistance to bacteriocins in contrast
may evolve via a variety of different routes. Bacteriocins are
important biological drivers underpinning the dynamics of com-
plex bacterial communities; consequently, resistance is a common
occurrence in nature.18 Many of the bacterial strains within these
communities already carry bacteriocins and their cognate immu-
nity genes. Also, because many members of a bacterial commu-
nity may share a common bacteriocin receptor, mutations to
that receptor that interfere with binding to one bacteriocin often
lead to resistance to others that exploit the same receptor. For
example, mutations in the vitamin B12 receptor BtuB confer resis-
tance to all nine E colicins (E1-9).19,20 Furthermore, many colicin-
like bacteriocins share a common translocation pathway, such
as the Ton or Tol pathways. Mutations in either pathway can
therefore lead to resistance against multiple bacteriocins. For
example, mutations in tonB can lead to resistance against colicins
Ia, Ib, B, D, G, H, M and V.21,22 Although superficially this might
seem like a major disadvantage for bacteriocin use, Ton and Tol
mutations incur significant fitness costs. Ton mutants lack the
ability to efficiently acquire iron, a key determinant for a success-
ful infection, and Tol mutants display highly permeable outer
membranes, leading to hypersensitivity to a range of toxic com-
pounds.23,24 Rooney et al. reported that although P. syringae
mutants with high levels of tolerance to the lectin-like bacteriocin
putidacin L1 were readily generated in vitro, the mutations all
involved genes with putative roles in lipopolysaccharide produc-
tion and conferred fitness costs.25
Although it is generally assumed thatmutations to critical genes
have a fitness cost, this may not necessarily be apparent under
laboratory growth conditions.18 Resistance to nisin does not
appear to confer significant fitness costs to L. monocytogenes
grown in a rich broth media or in a meat model,26 but at lower
temperatures and suboptimal NaCl concentrations mutants
exhibited a more pronounced drop in growth.26 Fitness costs
associated with resistance are of course in general dependent
on the metabolic activity associated with the mutant gene prod-
uct.18 The receptor for pyocin S2 is FpvA, which is involved in
the uptake of iron-bound pyoverdine. Pyocin S2 is most active
in iron-limiting conditions due to the requirement of an iron trans-
porter (FpvA) and its efficacy is dependent on the iron concentra-
tion of the growth medium.27,28 Furthermore, compared to wild-
type strains pyocin S2-resistant strains with FpvA mutations
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perform poorly in iron limiting conditions.29 Since a common
strategy of nutritional immunity against pathogenic bacteria is
restriction of iron by the host, the fitness cost of bacteriocin resis-
tance may be significant. The use of proteins involved in iron
transport as receptors is a feature of many colicin-like bacterio-
cins, with targets including FepA, CirA and FhuA. Another com-
mon target among bacteriocins is BtuB, which is required to
transport vitamin B12, an essential metabolite, into the cell.
Although information on the impact of bacteriocin resistance is
poorly understood for phytopathogenic bacteria, for colicin-like
bacteriocins the mechanisms of resistance are likely to follow a
common modus operandi. As described above, mutations in the
lipopolysaccharide (LPS) biosynthesis pathway in P. syringae con-
ferred insensitivity to the lectin-like bacteriocin, putidacin L1,25
most likely because of the effect of the mutations on the ability
of the bacteriocin to dock onto the outer membranes. Interest-
ingly, these mutations facilitated increased sensitivity to reactive
oxygen species and loss of bacterial motility.25 In A. tumefaciens
strains that evolved resistance to the small nucleotide antibiotic
Agrocin 84 30,31 (a structural mimic of a plant tumor-derived sub-
strate) resulted in the bacteria becoming avirulent in planta.32,33
Of course, the plasticity of bacterial physiologymay allow bacte-
rial phytopathogens to temporally evade transient selective pres-
sures (including protein antibiotics).34 In practice, for bacteriocins
to become a robust strategy for plant protection, bacteriocins will
likely need to be used in combinations (bacteriocin cocktails),
reducing the ability of bacteria to evade killing by single-use pro-
tein antibiotics. Such cocktails are probably already common in
nature, for example P. syringae pv. syringae B728a produces two
bacteriocins that work together in vitro to eliminate
competitors.35
4 APPLICATIONS OF PROTEIN
ANTIBIOTICS IN THE FIELD
The diversity and specificity of bacteriocins make them promising
biological agents for plant protection. Bacteriocins represent a
safer and more environmentally friendly alternative to conven-
tional antibiotics like streptomycin.36 Bacteriocins exhibit a nar-
row (highly specific) killing spectrum and where specific
examples have been assessed they have been classified by the
US Food and Drug Administration as ‘generally regarded as
safe’.37 Genetic modification and prophylactic application of bac-
teriocins represent the twomain routes for delivery in the context
of plant protection. We recently tested the potential of expressing
bacteriocins to improve plant health by genetically modifying
model plants (Arabidopsis and Nicotiana bethamiana) to express
the lectin-like bacteriocin putidacin. The expression of putidacin
L1 in both model organisms provided robust resistance against
a variety of field isolates of P. syringae.25 This approach shows
great potential, in particular given the potential improvements
that could be used to optimize the temporal and spatial expres-
sion in planta. Of course, despite the apparent attractive simplicity
of GM-based approaches there are considerable practical hurdles
to be overcome. GM crops are not accepted in many countries
and even in those where they are the costs of meeting regulatory
regulations can be considerable, meaning that the GM approach
will only be financially viable in high-volume/high-value crops.
The possible off-target effects of engineered bacteriocin-
expressing plants on the plant microbiome remain poorly under-
stood. Bacteriocins tend to exhibit a narrow killing spectrum (typ-
ically restricted to a single genus) but exhaustive testing against a
large panel of phylogenetically diverse strains would still be nec-
essary to demonstrate biosafety. For PL1, testing has been heavily
biased towards a few select bacterial genera that do not fully
reflect the complex nature of the plant microbiome.25,38–41 Wein-
hold and colleagues attempted to address this deficiency in the
literature by transforming wild tobacco plants (Nicotiana attenu-
ata) with the antimicrobial peptide ICE, which is potent against
a wide range of Bacillus strains.42 They found that the plant root
microbiome remained largely unaffected by the expression of
ICE in experimental field plots. A major caveat of this study was
that they were unable to confirm sufficient antimicrobial activity
of ICE in the roots. Thus, the results possibly reflect the technical
difficulties of expressing and/or delivering antimicrobial peptides
to their targets.42 Assessments of the diversity of the leaf micro-
biome of wild tobacco plants disclosed an extremely low level
of sequence depth (<40) in the leaves, indicating the bacterial
community has low complexity and species richness.42 Similar
results have been found with agave plants.43 These species
might not be ideal for assessing the impacts of expressing anti-
microbial peptides in the phyllosphere. Overall, literature in
this area remains sparse and further studies are key to establish
the viability of bacteriocins. Unless these technicalities can be
resolved engineering plants to express bacteriocins will not
be a viable control strategy for disease caused from soil-
dwelling pathogens like Ralstonia solanacearum,
P. carotovorum and P. atrosepticum. Despite the skepticism
behind the transgenic deployment of protein antibiotics, their
inherent specificity could mitigate the concerns on their influ-
ence on the global microbiome.
Another anxiety about the genetic transformation of crop plants
to express alien protein antibiotics is their potential to disrupt the
finely balanced biochemical equilibrium within plant cells, possi-
bly translating into significant yield penalties. Weinhold and col-
leagues did assess the holistic effects of expressing ICE in wild
tobacco and showed that the expression has no negative fitness
consequences in terms of plant growth performance, flower pro-
duction and herbivory.42 This single study, however, is not repre-
sentative of the sheer diversity of antibiotic proteins and if GM
approaches involving in planta expression of bacteriocins are to
gain traction an extensive effort to assess all potential off-target
effects will be required, potentially on a crop-by-crop basis. Pro-
phylactic (direct) application of bacteriocins to plants, seeds,
tubers etc. represents an alternative route for plant protection
that avoids many of the limitations of the GM-based approach.
In particular, the regulatory implications are far simpler and end
users have the flexibility to decide where, when and what crops
they wish to treat. Glasshouse experiments have demonstrated
that phage-like bacteriocins (tailocins) directly applied to tomato
and tobacco are highly effective at protecting against important
plant phytopathogenic bacteria.44,45 Tailocins are multicompo-
nent bacteriocins, making them difficult to produce in large-scale
in other model organisms.46 They can be produced in large-scale
fermenters but their economic viability has not been assessed. A
potential route for exploitation of tailocins could involve exploit-
ing commensal strains of bacteria that naturally produce them.
For example, the avirulent strain Pectobacterium carotovorum
pv. carotovorum CGE234-M403 harbors the tailocin CtvCGE and
is already marketed as ‘Biokeeper’ in Japan to manage bacterial
soft rot in potatoes.47
Single-gene bacteriocins are considerably easier to produce in
suitable quantities due to their solubility and low molecular
weight (30–70 kDa). Furthermore, techno-economic analysis of
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themanufacturing process using a plant-based platform has been
investigated.48 Indeed, plants make excellent potential platforms
for production of useful proteins such as bacteriocins. Plants have
been shown to produce active antimicrobial proteins with accu-
mulations as high as 3 g kg−1 of fresh weight.37,49–53 Economic
forecasts using three different scenarios project the manufactur-
ing cost of biopharming protein antibiotics from plants to be
$3.00–6.88 g−1.48 These production models include both the
upstream and downstream processes involved in the production
and purification of bacteriocins in the commonly used production
platform species N. benthamiana. The numbers suggest that
plants themselves represent the ideal platform for producing bac-
teriocins in industrial quantities.
5 CONCLUSION
Protein antibiotics represent a very promising approach to crop
protection that is desperately needed. The human population is
constantly rising, leading to huge demands in food availability,
with onset of the COVID-19 pandemic only exacerbating the crisis.
The exponential increase in published bacteria genomes and con-
stantly refined bacteriocin searches provides a continual source of
novel bacteriocins. Furthermore, niche host killing, which would
reduce the spread of bacteriocin resistance, and detrimental costs
to bacterial fitness and virulence after evolving resistance aug-
ments their use as a long-lasting antimicrobial.
Current approaches to crop protection are far from ideal as they
involve the use of chemical antimicrobials (e.g. copper-based che-
micals) or conventional antibiotics (e.g. Streptomycin) and their
widespread use often creates potentially serious environmental
and ecological side effects. Bacteriocins are likely to be much
more environmentally friendly because of their high target spec-
ificity and the consequent low probability of unintended effects
such as adverse changes to the plant or soil microbiome or the
transfer of resistance, potentially into human or animal as well
as plant bacterial pathogens. Of course, the downside of this high
degree of specificity is the likelihood that effective treatment reg-
imens will require the simultaneous use of multiple different bac-
teriocins (formulated into crop-specific bacteriocin cocktails).
Although this may appear to be a major drawback, the extraordi-
nary diversity and range of bacteriocins as evidenced by bioinfor-
matic analyses provides a roadmap for bacteriocin discovery,
formulation and use.
For crops grown on very large scales the GM approach (expres-
sing bacteriocins in planta) offers an innovative approach to crop
protection against bacterial pathogens. The expression of BT toxin
in GM crops such as cotton, maize etc. provides a direct example
of how such an approach can be both effective and economically
viable (albeit to control specific pests rather than pathogens). The
addition of genes expressing bacteriocins into transgene stacks
provides a route for introduction into existing GM crops. For crops
grown in lower volumes, or where the use of GM approaches is
not indicated or viable, the direct application of bacteriocin cock-
tails promises an effective, safe and economically viable approach
to crop protection.
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